# Multimodal Clinical Data Flow Architecture
**Status:** ACTIVE  
**Purpose:** Define how multimodal data streams integrate into unified clinical workflows

---

## DATA STREAMS → ANALYZERS → CLINICAL ACTIONS

```
┌─────────────────────────────────────────────────────────────────────────┐
│                    MULTIMODAL DATA INGESTION                            │
├─────────────────────────────────────────────────────────────────────────┤
│                                                                         │
│  LABS                IMAGING              NEURO                        │
│  ├─Blood work        ├─MRI               ├─qEEG                        │
│  ├─Hormones          └─CT                └─fMRI                        │
│  └─Metabolic         BEHAVIORAL          PHYSIOLOGICAL                 │
│                      ├─Digital phenotype ├─HRV                         │
│  VOICE/TEXT          ├─Sentiment         ├─Sleep                       │
│  ├─Recordings        ├─Activity logs     ├─Stress                      │
│  ├─Transcripts       └─Adherence        └─Recovery                     │
│  └─Sentiment                                                            │
│                      MOVEMENT            ASSESSMENT                     │
│  VIDEO               ├─Gait              ├─PHQ-9                       │
│  ├─Task videos       ├─Balance           ├─GAD-7                       │
│  ├─Session capture   └─Motor            └─Cognitive                    │
│  └─Webcam                                                              │
│                                                                         │
└─────────────────────────────────────────────────────────────────────────┘
                              ↓
┌─────────────────────────────────────────────────────────────────────────┐
│                  ANALYZER PROCESSING LAYER                              │
├─────────────────────────────────────────────────────────────────────────┤
│                                                                         │
│  ┌──────────────┐  ┌──────────────┐  ┌──────────────┐                 │
│  │ Biomarkers   │  │ Risk Triage  │  │ Biometrics   │                 │
│  │ (modality)   │  │ (synthesis)  │  │ (passive)    │                 │
│  └──────────────┘  └──────────────┘  └──────────────┘                 │
│                                                                         │
│  ┌──────────────┐  ┌──────────────┐  ┌──────────────┐                 │
│  │ Digital      │  │ NLP/Voice    │  │ Movement     │                 │
│  │ Phenotyping  │  │ Analysis     │  │ Biomarkers   │                 │
│  └──────────────┘  └──────────────┘  └──────────────┘                 │
│                                                                         │
│  ┌──────────────┐  ┌──────────────┐  ┌──────────────┐                 │
│  │ Sessions     │  │ Nutrition    │  │ Labs/Imaging │                 │
│  │ Tracking     │  │ Intelligence │  │ Specialist   │                 │
│  └──────────────┘  └──────────────┘  └──────────────┘                 │
│                                                                         │
└─────────────────────────────────────────────────────────────────────────┘
                              ↓
┌─────────────────────────────────────────────────────────────────────────┐
│              DEEPTWIN MULTIMODAL SYNTHESIS & SIMULATION                 │
├─────────────────────────────────────────────────────────────────────────┤
│  Unified Digital Twin:                                                  │
│  ├─ Neurophysiological state (qEEG + MRI + fMRI)                       │
│  ├─ Behavioral phenotype (movement + voice + digital phenotype)        │
│  ├─ Systemic health (labs + biometrics + nutrition)                    │
│  ├─ Longitudinal trajectory (all above, over time)                     │
│  └─ AI-assisted simulation (what-if intervention outcomes)             │
│                                                                         │
└─────────────────────────────────────────────────────────────────────────┘
                              ↓
┌─────────────────────────────────────────────────────────────────────────┐
│           CLINICAL ACTION LAYER (Interventions + Decisions)            │
├─────────────────────────────────────────────────────────────────────────┤
│                                                                         │
│  RISK-INFORMED DECISIONS                TREATMENT PLANNING            │
│  ├─ Safety gates (HIGH/MED/LOW)         ├─ Protocol matching          │
│  ├─ Escalation rules                    ├─ Dosing optimization        │
│  └─ Consent enforcement                 └─ Session scheduling         │
│                                                                         │
│  OUTCOME MONITORING                     PATIENT FEEDBACK              │
│  ├─ Treatment response (Sessions)       ├─ Subjective outcomes        │
│  ├─ Biomarker changes                   ├─ Adherence reporting        │
│  └─ Adverse signals (Risk Triage)       └─ Goal progress              │
│                                                                         │
└─────────────────────────────────────────────────────────────────────────┘
                              ↓
                      CLOSED LOOP
             (Actions feed back to Sessions →
              Outcomes → Biomarkers → DeepTwin)
```

---

## CLINICAL WORKFLOW: MULTIMODAL INTEGRATION EXAMPLE

**Scenario:** New patient with treatment-resistant depression (TRD)

### Day 1: Intake & Assessment
```
Clinician initiates patient intake
  ↓
Assessments Analyzer: PHQ-9 administered (71/90 severity)
  → Biomarkers Analyzer: score flagged as high severity
  → Risk Triage: HIGH RISK (suicidality screen positive)
  ↓
Risk Triage gate: Intervention requires supervision
Clinician confirms safety plan
  ↓
DeepTwin: Creates baseline patient model
  - No imaging yet (request MRI + qEEG)
  - Behavioral profile: anhedonia, sleep disruption
  - Labs: Inflammation markers pending
```

### Week 1: Multimodal Assessment Phase
```
qEEG Analyzer: EEG data uploaded
  → Biomarkers: Theta/alpha excess, reduced posterior alpha power
  → DeepTwin: Neurophysiology component added
  ↓
Labs Analyzer: Blood work complete
  → B12, D, iron deficiency detected
  → Inflammation (CRP, IL-6) elevated
  → Biomarkers: Micronutrient deficiencies flagged
  → Nutrition Analyzer: Supplementation plan suggested
  ↓
MRI Analyzer: MRI completed
  → No structural abnormalities detected
  → Normal age-expected volumetry
  → DeepTwin: Imaging integrated
  ↓
Biometrics Analyzer: Apple Watch synced
  → Sleep: 5h/night, fragmented
  → HRV low, stress elevated
  → DeepTwin: Physiological trends captured
```

### Week 2: Protocol Selection
```
DeepTwin generates protocol recommendations
  → TMS frequency? Neuromod targets?
  → Medication + therapy combo?
  → Nutrition optimization first?
  ↓
Clinician reviews recommendation:
  "Micronutrient repletion (B12 + D + iron) + nutritional counseling
   + targeted TMS to dlPFC (right > left) + sertraline titration"
  ↓
Brain Map Planner: Interactive target selection
  → qEEG + MRI overlaid
  → Clinician confirms dlPFC target sites
  → Device planning: Consider Magventure vs Neurosoft
  ↓
Intervention Studio: Protocol authoring
  → TMS: 10 Hz, 120% RMT, 3000 pulses, 5x/week × 6 weeks
  → Nutrition: B12 supplementation + dietary changes
  → Sessions Analyzer: Begin tracking adherence
```

### Weeks 3-8: Treatment & Real-Time Monitoring
```
Each TMS session:
  → Sessions Analyzer logs: date, parameters, tolerability
  → Post-session: PHQ-9 brief check-in
  → Biometrics: Real-time HRV/sleep tracking
  ↓
Weekly check-ins:
  → Risk Triage: Suicidality screen (on schedule)
  → DeepTwin update: Twin evolves with each data point
  → Clinician review: "Response trajectory +20% improvement"
  ↓
Wk 5: Voice Analyzer on TMS session recordings
  → Speech rate increased (positive sign)
  → Pitch elevation (mood improvement signal)
  → Digital Phenotype: Behavioral inference
  ↓
Labs Analyzer (Wk 6 recheck):
  → B12/D/iron normalizing
  → Inflammation still elevated → extend nutrition phase
  → Biomarkers trend: micro improvements
```

### Week 9: Outcome Assessment
```
Biomarkers Analyzer: Full composite assessment
  → PHQ-9: 28/90 (50% improvement) ✓
  → qEEG: Theta reduction, alpha normalization ✓
  → Labs: Inflammatory markers trending down ✓
  → Biometrics: Sleep 7h/night, HRV improved ✓
  → DeepTwin: Twin predicts continued improvement
  ↓
Risk Triage: Reassessment
  → MEDIUM RISK (improved from HIGH)
  → Suicidality screen: Negative
  → Continue treatment, taper supervision
  ↓
Reports: Generate longitudinal report
  → 8-week treatment effectiveness summary
  → Biomarker changes correlate with functional improvement
  → Recommendation: continue TMS 2x/week maintenance
```

---

## ANALYZER INTERDEPENDENCIES

### Critical Path (must work for clinical safety)
```
Risk Triage ← Assessments ← Patient
            ← Biomarkers
            ← Sessions
Risk Triage → Interventions (safety gate)
Risk Triage → Dashboard (alerts)
```

### Secondary Path (workflow efficiency)
```
DeepTwin ← ALL analyzers
DeepTwin → Interventions (protocol rec)
DeepTwin → Reports (research)
```

### Tertiary Path (enrichment)
```
Sessions → Biomarkers (treatment response tracking)
Text/Voice → Risk Triage (NLP risk detection)
Digital Phenotype → Risk Triage (behavioral risk)
```

---

## REAL-TIME VS BATCH PROCESSING

### Real-Time (Latency <2s)
- Risk Triage scoring
- Dashboard alerts
- Session logging
- Biometric sync (polling 5-min intervals)

### Batch (Async, 1-60min)
- qEEG analysis (complex signal processing)
- MRI segmentation (AI models)
- NLP on documents (LLM calls)
- DeepTwin synthesis (integrates all sources)
- Population reports (nightly aggregation)

---

## CONSENT & GOVERNANCE REQUIREMENTS

| Data Stream | Consent Required | Retention | Audit |
|-------------|-----------------|-----------|-------|
| Labs | Medical record release | Permanent | Automatic |
| Imaging | HIPAA + imaging consent | 7 years | Automatic |
| qEEG | Neuroimaging research (if db access) | 5 years | Automatic |
| Voice | Audio recording + transcription | 2 years (purge on demand) | Automatic |
| Video | Media consent (explicit) | 1 year (purge after tx complete) | Automatic |
| Wearables | Passive sensor consent | 1 year | Automatic |
| Digital Phenotype | Strict privacy consent | 90 days (rolling) | Weekly audit |

---

## SCALABILITY: FROM 1 PATIENT TO 10,000

### Current Architecture
- Single clinic: 50-100 active patients
- Analyzers process on-demand (patient opens page)
- Batch jobs nightly (reports, population analytics)

### Scale to 10,000 patients
- **Caching:** Biomarker summaries cached 6h
- **Queuing:** Analyzer jobs → async task queue (Celery)
- **Parallel:** qEEG + MRI analysis run in parallel
- **Sharding:** Patient data partitioned by clinic ID
- **Database:** Time-series DB for biomarker history (InfluxDB or TimescaleDB)

---

## SUCCESS METRICS

1. **Clinical Adoption**: >70% of clinicians use DeepTwin for intervention planning within 3 months
2. **Safety**: Risk Triage alerts prevent 100% of missed HIGH-RISK cases (zero false negatives)
3. **Accuracy**: Biomarker findings match expert assessment >85% of the time
4. **Speed**: Multimodal synthesis available within <10s of patient page load
5. **Compliance**: 100% audit trail, consent enforcement, HIPAA compliance verified quarterly

